Article Figures & Data
Figures
- Figure 1.
Representative IHC staining. A: Positive expression of E-cadherin with brown stained membranes of pre-treatment tumour in case 8. B: Positive expression of E-cadherin with brown stained membranes of post-treatment tumour is shown in case 8. C: Positive expression of gamma-catenin with brown stained cytoplasm of a pre-treatment tumour in case 1. D: Negative expression of gamma-catenin of post-treatment tumour in case 1. E: Negative expression of fibronectin of pre-treatment tumour in case 8. F: Positive expression of fibronectin with brown stained membrane of post-treatment tumour in case 8. G: Negative expression of vimentin of pre-treatment tumour in case 2. H: Positive expression of vimentin with brown stained membrane and cytoplasm of post-treatment tumour in case 2. Original magnification is ×100 in all cases.
- Figure 2.
The mean proportion scores in a comparison between refractory and sensitive tumours are shown. Error bar: mean±standard deviation. S: Gefitinib-sensitive tumour, R: gefitinib-resistant tumour, E: E-cadherin, G: gamma-catenin, F: fibronectin, V: vimentin.
Tables
In this issue
Jump to section
Related Articles
Cited By...
- Antitumor Activity of Eribulin After Fulvestrant Plus CDK4/6 Inhibitor in Breast Cancer Patient-derived Xenograft Models
- A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
- Integrative Omics Analysis Reveals Soluble Cadherin-3 as a Survival Predictor and an Early Monitoring Marker of EGFR Tyrosine Kinase Inhibitor Therapy in Lung Cancer
- CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
- Engineering Multidimensional Evolutionary Forces to Combat Cancer
- Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
- Expression of Neuroendocrine Factor VGF in Lung Cancer Cells Confers Resistance to EGFR Kinase Inhibitors and Triggers Epithelial-to-Mesenchymal Transition
- The neuropilin 2 isoform NRP2b uniquely supports TGF{beta}-mediated progression in lung cancer
- Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors
- Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition
- Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma
- Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells
- Metformin Sensitizes EGFR-TKI-Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal
- A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors
- Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
- Response to Erlotinib in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancers with a Squamous or Squamous-like Component
- Prognostic Value of Aquired Resistance-related Molecules in Japanese Patients with NSCLC Treated with an EGFR-TKI
- Complex Role of Histone Deacetylase Inhibitors in the Treatment of Non-Small-Cell Lung Cancer
- Biomarkers for EGFR-Antagonist Response: In the Genes and on the Genes!
- The Expression of CD146 Predicts a Poor Overall Survival in Patients with Adenocarcinoma of the Lung
- The EMT Status in the Primary Tumor Does Not Predict Postoperative Recurrence or Disease-free Survival in Lung Adenocarcinoma
- Molecular Diagnosis of MACC1 Status in Lung Adenocarcinoma by Immunohistochemical Analysis
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- Lack of Direct Association between EGFR Mutations and ER Beta Expression in Lung Cancer
- Immunohistochemical Staining with DeltaNp63 Is Useful for Distinguishing the Squamous Cell Component of Adenosquamous Cell Carcinoma of the Lung